Literature DB >> 16964801

Application of the Genotype MTBDR assay directly on sputum specimens.

D Hillemann1, S Rüsch-Gerdes, E Richter.   

Abstract

The Genotype MTBDR assay was tested for its capability to detect rifampicin (RMP) and isoniazid (INH) resistance (r) and susceptibility (s) directly from 42 smear-positive sputum specimens (15 RMPr/INHr, 2 RMPs/INHr and 25 RMPs/INHs Mycobacterium tuberculosis complex strains). The concordance between the MTBDR assay and conventional drug susceptibility testing was 100%.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16964801

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  16 in total

1.  Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method.

Authors:  Raquel Moure; Laura Muñoz; Miriam Torres; Miguel Santin; Rogelio Martín; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

2.  Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges.

Authors:  Giovanni Battista Migliori; Alberto Matteelli; Daniela Cirillo; Madhukar Pai
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

3.  Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.

Authors:  Sven O Friedrich; Amour Venter; Xavier A Kayigire; Rodney Dawson; Peter R Donald; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

4.  Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.

Authors:  Susan E Dorman; Violet N Chihota; James J Lewis; Minty van der Meulen; Barun Mathema; Natalie Beylis; Katherine L Fielding; Alison D Grant; Gavin J Churchyard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 5.  Alternative methods of diagnosing drug resistance--what can they do for me?

Authors:  David A J Moore; N Sarita Shah
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

6.  Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

7.  Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates.

Authors:  R Vijdea; M Stegger; A Sosnovskaja; A B Andersen; V Ø Thomsen; D Bang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-05       Impact factor: 3.267

8.  Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire.

Authors:  K N'guessan; J S Assi; T Ouassa; J M Ahui-Brou; A Tehe; M Keita Sow; A Guei; J Kouakou; M Dosso
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-09-11

9.  Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

10.  Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis.

Authors:  Danny C T Ong; Wing-Cheong Yam; Gilman K H Siu; Ann S G Lee
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.